Immune Sera and Immunoglobulins

DrugDrug NameDrug Indication
DB00110PalivizumabFor prophylaxis of respiratory diseases casued by respiratory syncytial virus.
DB06310MotavizumabInvestigated for use/treatment in viral infection and pediatric indications.
DB08902RaxibacumabRaxibacumab is indicated for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs, and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.
DB10062Rabies virus inactivated antigen, BNot Available
DB10283Rabies virus inactivated antigen, ANot Available
DB11604Tetanus Immune GlobulinFor use as prophylaxis against tetanus in patients who are injured and have incomplete of uncertain immunization statu [FDA Label]. May also be used in the treatment of active tetanus.
DB13535NebacumabNot Available
DB13886Human cytomegalovirus immune globulinIt is used to prevent cytomegalovirus (CMV) disease after organ transplant [L2225]. Cytomegalovirus Immune Globulin Intravenous (Human) is indicated for the prophylaxis of cytomegalovirus disease associated with transplantation of kidney, lung, liver, pancreas, and heart [FDA label]. In transplants of these organs other than the kidney from CMV seropositive donors into seronegative recipients, prophylactic CMV-IGIV should be considered in combination with ganciclovir [FDA label].
DB05336ObiltoxaximabInvestigated for use/treatment in anthrax exposure, bacterial infection, crohn's disease, and graft versus host disease.
DB13140BezlotoxumabPrevents recurrence of Clostridium difficile infection in people 18 years or older who are either currently receiving treatment for C. difficile infection or have a high risk of recurrence.